24.11.2011FDA approves BELOTERO Balance®: Success of a promising partnership between Anteis & Merz Aesthetics
You are here
NewsFDA approves BELOTERO Balance®: Success of a promising partnership between Anteis & Merz Aesthetics
BELOTERO Balance® has now been approved
by the US Food and Drug Administration (FDA) for injection into the mid-to-deep dermis to correct moderate-to-severe facial wrinkles and folds such as nasolabial folds.
by the US Food and Drug Administration (FDA) for injection into the mid-to-deep dermis to correct moderate-to-severe facial wrinkles and folds such as nasolabial folds.
BELOTERO Balance® is a hyaluronic acid-based cohesive gel dermal filler that delivers natural-looking results with little recovery time. Practitioners and patients will now have a breakthrough alternative in aesthetic medicine with BELOTERO Balance® “thanks to a successful partnership between Anteis, a Swiss leader in aesthetic dermatology, ophthalmology and orthopaedics, and Merz Aesthetics, a division of Merz Pharmaceuticals in Germany”, added Gilles Bos and Dennis Condon.
Find an actor
